111 records matched your query
03514aam a2200589 i 4500 001 8C4905F4774811E7923FA1BEDAD10320 003 SILO 005 20170802010138 008 170130t20172017nyua b 001 0 eng c 010 $a 2017004139 020 $a 1107168481 020 $a 9781107168480 035 $a (OCoLC)971615468 040 $a DNLM/DLC $b eng $e rda $c DLC $d NLM $d OCLCO $d BDX $d OCLCQ $d BTCTA $d YDX $d YDX $d OCLCO $d OCLCF $d SILO 042 $a pcc 043 $a n-us--- 050 04 $a RA401.A3 $b D78 2017 060 10 $a QV 736 AA1 082 00 $a 338.4/76151 $2 23 100 1 $a Feldman, Robin, $e author. 245 10 $a Drug wars : $b how big pharma raises prices and keeps generics off the market / $c Robin Feldman, Evan Frondorf. 264 1 $a New York, NY : $b Cambridge University Press, $c 2017. 300 $a xii, 151 pages ; $c 24 cm 504 $a Includes bibliographical references and index. 505 8 $a Machine generated contents note: Introduction: big scandals, higher prices; 1. The winding road to generic entry; 2. 'Generation 1.0': the rise and fall of traditional pay-for-delay; 3. 'Generation 2.0': complicating pay-for-delay; 4. 'Generation 3.0': new tactics for active obstruction of generics; 5. 'Generation 3.0' continued: obstruction of regulatory pathways; 6. Empirical evidence of a citizen's pathway gone astray; Conclusion: a call for systematic reform. 520 $a "While the shockingly high prices of prescription drugs continue to dominate the news, the strategies used by pharmaceutical companies to prevent generic competition are poorly understood, even by the lawmakers responsible for regulating them. In this groundbreaking work, Robin Feldman and Evan Frondorf illuminate the inner workings of the pharmaceutical market and show how drug companies twist health policy to achieve goals contrary to the public interest. In highly engaging prose, they offer specific examples of how generic competition has been stifled for years, with costs climbing into the billions and everyday consumers paying the price. Drug Wars is a guide to the current landscape, a roadmap for reform, and a warning of what is to come. It should be read by policymakers, academics, patients, and anyone else concerned with the soaring costs of prescription drugs"--Provided by publisher. 650 0 $a Drugs $z United States $x Costs. 650 0 $a Pharmaceutical policy $z United States. 650 0 $a Pharmaceutical industry $z United States. 650 0 $a Generic drugs. 650 12 $a Drug Costs. 650 22 $a Drugs, Generic $x supply & distribution. 650 22 $a Patents as Topic. 650 22 $a Drug Industry $x economics. 650 22 $a Drug Industry $x legislation & jurisprudence. 650 22 $a Economic Competition $x legislation & jurisprudence. 651 2 $a United States. 650 7 $a Drugs $x Costs. $2 fast $0 (OCoLC)fst00898787 650 7 $a Generic drugs. $2 fast $0 (OCoLC)fst00939969 650 7 $a Pharmaceutical industry. $2 fast $0 (OCoLC)fst01060129 650 7 $a Pharmaceutical policy. $2 fast $0 (OCoLC)fst01060194 651 7 $a United States. $2 fast $0 (OCoLC)fst01204155 700 1 $a Frondorf, Evan, $e author. 941 $a 6 952 $l CEAX572 $d 20200508022526.0 952 $l OVUX522 $d 20200318013853.0 952 $l HWAX074 $d 20180926012745.0 952 $l PNAX964 $d 20180925010451.0 952 $l USUX851 $d 20180802013419.0 952 $l UQAX771 $d 20180515030358.0 956 $a http://locator.silo.lib.ia.us/search.cgi?index_0=id&term_0=8C4905F4774811E7923FA1BEDAD10320 994 $a 92 $b IWAInitiate Another SILO Locator Search